We are live on ! Find out more

285 hedge funds and large institutions have $6.16B invested in Qiagen in 2023 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 109 increasing their positions, 92 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more call options, than puts

Call options by funds: $24.5M | Put options by funds: $19.1M

18% more repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 92

6% more capital inflows, than outflows

Capital inflows: $668M | Capital outflows: $628M

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

0.82% less ownership

Funds ownership: 59.79% → 58.97% (-0.82%)

4% less funds holding

Funds holding: 297 → 285 (-12)

20% less first-time investments, than exits

New positions opened: 33 | Existing positions closed: 41

Holders
285
Holders Change
-12
Holders Change %
-4.04%
% of All Funds
4.53%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
33
Increased
109
Reduced
92
Closed
41
Calls
$24.5​M
Puts
$19.1​M
Net Calls
+$5.35​M
Net Calls Change
-⁠$18.2​M

QGEN Hedge Fund Activity: Q1 2023 in Review

285 of the 6,286 institutional investors tracked by Wall St. Rank reported a position in Qiagen (QGEN) for Q1 2023, worth a combined $6.16B — down 9.3% from $6.79B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of QGEN and 33 opened new positions — a net loss of 8 holders — while 92 trimmed existing stakes and 109 added.

The largest buyer was DZ Bank, adding an estimated $63.1M. The largest seller was Amundi, cutting an estimated $136M.

  • 285 institutional investors held Qiagen (QGEN) as of Q1 2023, down from 297 in Q4 2022.
  • Funds reported $6.16B of Qiagen stock for Q1 2023, down 9.3% quarter-over-quarter.
  • 33 funds opened new Qiagen positions in Q1 2023 and 41 closed out, a net change of -8 holders.
  • The largest Qiagen buyer in Q1 2023 was DZ Bank, an estimated $63.1M added.
  • The largest Qiagen seller in Q1 2023 was Amundi, an estimated $136M sold.

Based on aggregated 13F filings for Q1 2023.